CD73 is a novel repressor of mutant β-catenin oncogenic activity in endometrial cancer

被引：0
|
作者：
Hirsch, Rebecca M.
Zhang, Xingyuan
Chiou, Lilly F.
Premsankar, Sunthoshini
Lee, Hannah N.
Kurnit, Katherine C.
Broaddus, Russell R.
Vaziri, Cyrus
Bowser, Jessica L.
机构：
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 05期
关键词：
D O I：
10.1158/1557-3265.ENDO24-PR004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR004
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CD73 sequestering mutant β-catenin at the membrane explains recurrence in CTNNB1 mutant endometrial cancer.
    Bowser, Jessica L.
    Kurnit, Katherine C.
    Phan, Luan H.
    Harvey, Jerry B.
    Feng, Jiping
    Xie, Susu
    Gladden, Andrew B.
    McCrea, Pierre D.
    Broaddus, Russell R.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [2] Novel CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (05): : 571 - 572
  • [3] CD73: A Novel Target for Cancer Immunotherapy
    Zhang, Bin
    CANCER RESEARCH, 2010, 70 (16) : 6407 - 6411
  • [4] Harnessing the unique biology of CD73 for improving endometrial cancer outcomes
    Bowser, Jessica L.
    Lee, Hannah N.
    Hirsch, Rebecca H.
    Zhang, Xingyuan
    Broaddus, Russell R.
    Kurnit, Katherine C.
    Crumley, Suzanne M.
    Premsankar, Sunthoshini
    Rabjohns, Emily M.
    Chiou, Lilly F.
    Vaziri, Cyrus
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [5] The Roles of CD73 in Cancer
    Gao, Zhao-wei
    Dong, Ke
    Zhang, Hui-zhong
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [6] Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 775 - 776
  • [7] CD73 as a novel prognostic biomarker for human colorectal cancer
    Liu, Nan
    Fang, Xue-Dong
    Vadis, Quo
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (07) : 918 - 919
  • [8] The Clinical Significance of CD73 in Cancer
    Bach, Niklas
    Winzer, Riekje
    Tolosa, Eva
    Fiedler, Walter
    Brauneck, Franziska
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [9] CD73 as a target in cancer immunotherapy
    Smyth, Mark J.
    Beayis, Paul
    Darcy, Phil K.
    Loi, Sherene
    Stagg, John
    CANCER RESEARCH, 2012, 72
  • [10] CBO421, a novel drug Fc-conjugate, inhibits the enzymatic activity of CD73 and triggers CD73 internalization
    Abelovski, Elizabeth
    Dedeic, Nicholas
    Dohrmann, Simon
    Levin, James
    Almaguer, Amanda
    Zuill, Doug
    Fortier, Joanne
    Zhao, Qiping
    Hernandez, Maria
    Amundson, Karin
    Moniz, Madison
    Chen, Hongyuan
    Panickar, Dhanya
    Lam, Thanh
    Brady, Tom
    Borchardt, Allen
    Hough, Grayson
    Locke, Jeffrey B.
    Cole, Jason N.
    Tari, Leslie W.
    CANCER RESEARCH, 2024, 84 (07)
12345